Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Christos Sotiriou
Based on 143 articles published since 2007
||||
Expertise Level
The expertise of Christos Sotiriou ranks in the
  • Top 0.019%
  • ... of 253,558 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 143 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Sotiriou, C   ·   Sotiriou, Christos
Work Locations
Details
Most likely:    Jules Bordet Institute      
2017
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Department of Internal Medicine (DiMI), University of Genoa and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-National Cancer Institute, Genoa, Italy. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium; Department of Pathology/TCRU, Sint Augustinus, Wilrijk, Belgium. · Pubmed 28400203
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Department of Pathology, University Hospitals Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium. · Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center (VRC), Vlaams Instituut voor Biotechnologie (VIB) and KU Leuven, Leuven, Belgium. · Pubmed 28673354
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Sciences and Community Health, Unit of Medical Statistics, Biometry and Bioinformatics 'Giulio A. Maccacaro', University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus Campus, Wilrijk, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Gosselies, Belgium. · Pubmed 28621322
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
  • Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. · Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA. · Genome and Systems Biology Degree Program, National Taiwan University, Taipei 10617, Taiwan. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, University Libre de Bruxelles, Brussels 1000, Belgium. · Magee-Women's Research Institute, Pittsburgh, PA 15213, USA. · Pubmed 28031185
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 27737921
2016
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Department of Oncology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Surgery, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Humanitas University, Rozzano-Milan, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Immunology and Inflammation, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Pubmed 27912781
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. · Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.; Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium. · Department of Gastroenterology and Hepatology, Chinese People's Liberation Army General Hospital, Beijing 100853, China. · Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Pubmed 27617288
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Translational Breast Cancer Laboratory, Free University of Brussels, Institute Jules Bordet, Brussels, Belgium. · GBG German Breast Group, Neu Isenburg, Germany. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · Multidisciplinary Breast Center, KU Leuven, University Hospitals, Leuven, Belgium. · Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27172896
  • European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridgeshire CB10 1SD, UK. · Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Faculty of Science, Department of Molecular Biology, 6525GA Nijmegen, The Netherlands. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, and department of Laboratory Medicine, Radboud university medical center, Nijmegen 6525GA, The Netherlands. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium and Center for Oncological Research, University of Antwerp, Antwerp B-2610, Belgium. · Centre for Clinical Research and School of Medicine, University of Queensland, Brisbane, Queensland 4059, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street,Houston, Texas 77030, USA. · Department of Surgical Oncology, University of Dundee, Dundee DD1 9SY, UK. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Pubmed 27136393
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26621457
  • Laboratory of Structure and Function of Biological Membranes, Center of Structural Biology and Bioinformatics, Université Libre de Bruxelles, Brussels, Belgium. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathological Anatomy Department, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 26535413
  • Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium. · Department of Medical Oncology, Oncologisch Centrum, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 26010302
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Pubmed 26063634
  • Departement de Medecine, BrEAST Data Centre, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 26527804
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • Department of Pathology, GZA Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Medicine, Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25066860
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Université Libre de Bruxelles, IRIBHM, Brussels B-1070, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels B-1000, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels B-1070, Belgium. · DIAPATH - Center for Microscopy and Molecular Imaging (CMMI), Gosselies B-6041, Belgium. · Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne 3002, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 3002, Australia. · WELBIO, Université Libre de Bruxelles, Brussels B-1070, Belgium. · Pubmed 26266985
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Oncology, The University of Cambridge, Cambridge, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · 1] Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway. [2] Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Human Genetics, University of Leuven, Leuven, Belgium. · Department of Surgery, Haukeland University Hospital, Bergen, Norway. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · 1] Department of Pathology, Haukeland University Hospital, Bergen, Norway. [2] The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26099045
  • IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · WELBIO, 808 route de Lennik, 1070, Brussels, Belgium. · Pubmed 25884932
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • Breast Cancer Translational Research Laboratory (BCTL), Institut Jules Bordet, Brussels, Belgium. · Pubmed 25412710
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2009
  • Medical Oncology Department, Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19228622
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
  • Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Christine Desmedt, Gabriele Zoppoli, Denis Larsimont, Debora Fumagalli, David Brown, Françoise Rothé, Delphine Vincent, Naima Kheddoumi, Ghizlane Rouas, Samira Majjaj, Sylvain Brohée, Roberto Salgado, Martine Piccart-Gebhart, and Christos Sotiriou, Institut Jules Bordet; Christine Galant, Cliniques Universitaires Saint Luc, Brussels; Peter Van Loo, University of Leuven; Thomas Van Brussel and Diether Lambrechts, VIB Vesalius Research Center, Leuven, Belgium; Gabriele Zoppoli, University of Genoa and Istituto di Ricerca a Carattere Clinico-Scientifico San Martino-National Cancer Institute, Genoa; Giancarlo Pruneri, Patrick Maisonneuve, and Giuseppe Viale, European Institute of Oncology; Marco Fornili and Elia Biganzoli, University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy; Gunes Gundem and Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridgeshire; Peter Van Loo, The Francis Crick Institute, London, United Kingdom; Ron Bose, Washington University School of Medicine, St Louis, MO; Otto Metzger, Dana-Farber Cancer Institute, Boston, MA; and François Bertucci, Institut Paoli-Calmettes, Marseille, France. · Pubmed 26926684
2015
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2013
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000 Brussels, Belgium. · Pubmed 23881035
  • Department of Medicine, Institute Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22910839
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium. · Pubmed 23301057
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Pubmed 23014189
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 23012296
  • Breast Cancer Translational Research Unit, Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium. · Pubmed 22964299
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
  • Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, 125 Bld de Waterloo, Brussels 1000, Belgium. · Pubmed 22235100
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 125, 1000, Brussels, Belgium. · Pubmed 22527490
2011
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21918439
  • Institut Jules Bordet, 121 Boulevard de Waterloo, B-1000 Brussels, Belgium. · Pubmed 20138540
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Pubmed 21264346
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 20953831
2010
  • Jules Bordet Institute, Translational Research Unit, Universite Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 20943601
  • Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium. · Pubmed 20706122
  • Breast Cancer Translational Research Laboratory JC Heuson, Jules Bordet Institute, Brussels, Belgium. · Pubmed 20856894
  • Department of Research, Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia. · Pubmed 20479250
  • Functional Genomics and Translational Research Unit, Medical Oncology Department, Jules Bordet Institute, Boulevard de Waterloo, Brussels, 1000, Belgium. · Pubmed 20156340
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 20043280
2009
  • Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 19191098
  • Department of Medical Oncology, Jules Bordet Institute, Rue Heger-Bordet 1, Brussels, Belgium. · Pubmed 19914538
  • Translational Research Unit, Jules Bordet Institute, Brussels, Belgium. · Pubmed 19744330
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
  • Department of Medical Oncology, Jules Bordet Institute, Brussels. · Pubmed 19214112
Probable:    Universite Libre de Bruxelles      
2017
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Department of Internal Medicine (DiMI), University of Genoa and Istituto di Ricovero e Cura a Carattere Scientifico San Martino-National Cancer Institute, Genoa, Italy. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium; Department of Pathology/TCRU, Sint Augustinus, Wilrijk, Belgium. · Pubmed 28400203
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Department of Pathology, University Hospitals Leuven, Herestraat 49, B-3000, Leuven, Belgium. · Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium. · Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center (VRC), Vlaams Instituut voor Biotechnologie (VIB) and KU Leuven, Leuven, Belgium. · Pubmed 28673354
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Sciences and Community Health, Unit of Medical Statistics, Biometry and Bioinformatics 'Giulio A. Maccacaro', University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus Campus, Wilrijk, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Gosselies, Belgium. · Pubmed 28621322
  • WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium. · WELBIO and Institute of Interdisciplinary Research (IRIBHM), Campus Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Laboratoire de Biologie Moléculaire du Gène, Faculté des Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Tumor Bank of the Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Biobank of the Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium · Pubmed 28566333
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 27737921
2016
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Department of Gynecology and Obstetrics, Ludwig-Maximilians-Universität, Munich, Germany. · Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Center of Experimental Medicine, Hamburg, Germany. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and ACR-ITR VIEnna, Kaiser Franz Josef-Spital, Kundratstrasse 3, 1100 Vienna, Austria. · Medical and Scientific Affairs, F. Hoffmann-La Roche AG, Diagnostics Division, Basel, Switzerland. · European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. · Breast International Group Headquarters, Brussels, Belgium. · Janssen Diagnostics LLC, NJ, USA. · Department of Gynecology and Obstetrics, Universitätsklinikum Ulm, Ulm, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Circulating Biomarker Lab, SIRIC, Institut Curie, Paris, France; Medical Oncology Department, Institut Curie, Université Paris Descartes, France. · Pubmed 27289552
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Breast and Gynecological Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Avera Cancer Institute, Sioux Falls, South Dakota. · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Bern, Switzerland. · Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark6Danish Breast Cancer Cooperative Group, Copenhagen, Denmark11Department of Oncology, Odense University Hospital, Odense, Denmark12AgeCare, Odense University Hospital, Odense. · Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France14INSERM U1018, CESP, Université Paris-Sud, Villejuif France. · Pubmed 26633571
  • Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Department of Oncology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Surgery, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Humanitas University, Rozzano-Milan, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Immunology and Inflammation, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Pubmed 27912781
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. · Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.; Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium. · Department of Gastroenterology and Hepatology, Chinese People's Liberation Army General Hospital, Beijing 100853, China. · Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, 1050 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.; Interuniversity Institute of Bioinformatics Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium. · Pubmed 27617288
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridgeshire CB10 1SD, UK. · Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos NM 87545, New Mexico, USA. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Faculty of Science, Department of Molecular Biology, 6525GA Nijmegen, The Netherlands. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, and department of Laboratory Medicine, Radboud university medical center, Nijmegen 6525GA, The Netherlands. · Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Wilrijk, Belgium and Center for Oncological Research, University of Antwerp, Antwerp B-2610, Belgium. · Centre for Clinical Research and School of Medicine, University of Queensland, Brisbane, Queensland 4059, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street,Houston, Texas 77030, USA. · Department of Surgical Oncology, University of Dundee, Dundee DD1 9SY, UK. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Pubmed 27136393
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26621457
  • Laboratory of Molecular and Medical Oncology, Vrije Universiteit Brussel, Brussels, Belgium. · Department of Medical Oncology, Oncologisch Centrum, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Brussels, Belgium. · Pubmed 26010302
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · Department of Medical Oncology and Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels · Pubmed 26063634
  • Departement de Medecine, BrEAST Data Centre, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 26527804
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26352893
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Electronic address: · EORTC Headquarters, Brussels, Belgium. Electronic address: · Division of Medical Oncology, Second University of Naples, Naples, Italy. Electronic address: · KU Leuven - University of Leuven, Department of Oncology, Experimental Radiation Oncology, B-3000 Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, B-3000 Leuven, Belgium. Electronic address: · Medical University of Vienna, Vienna, Austria. Electronic address: · Institut de Cancérologie Gustave-Roussy, Villejuif, France; University Paris-Sud, Le Kremlin Bicêtre, Paris, France. Electronic address: · University of Dublin, Trinity College, Dublin, Ireland. Electronic address: · Université Paris Descartes, Paris, France. Electronic address: · Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · VU Medical Center, Amsterdam, The Netherlands. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · University Hospitals Leuven and KU Leuven, Leuven, Belgium. Electronic address: · Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 25533737
  • Department of Pathology, GZA Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Medicine, Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25066860
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Department of Internal Medicine, University of Genova and IRCCS AOU San Martino - IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo, 121, Brussels, Belgium. · Pubmed 26467651
  • Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Department of Pathology, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Molecular Immunology Unit, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. · Department of Genetics, Hôpital Erasme, Route de Lennik, 808-1070 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium; Department of Medicine, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium. Electronic address: · IRIBHM, Université Libre de Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium; WELBIO, Route de Lennik, 808-1070 Brussels, Belgium. Electronic address: · Pubmed 26440892
  • Université Libre de Bruxelles, IRIBHM, Brussels B-1070, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels B-1000, Belgium. · Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels B-1070, Belgium. · DIAPATH - Center for Microscopy and Molecular Imaging (CMMI), Gosselies B-6041, Belgium. · Surgical Oncology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne 3002, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 3002, Australia. · WELBIO, Université Libre de Bruxelles, Brussels B-1070, Belgium. · Pubmed 26266985
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Oncology, The University of Cambridge, Cambridge, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · 1] Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway. [2] Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Human Genetics, University of Leuven, Leuven, Belgium. · Department of Surgery, Haukeland University Hospital, Bergen, Norway. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · 1] Department of Pathology, Haukeland University Hospital, Bergen, Norway. [2] The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26099045
  • IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bld de Waterloo, 125-1000, Brussels, Belgium. · IRIBHM - Université Libre de Bruxelles, ULB, Campus Erasme CP602, 808 route de Lennik, 1070, Brussels, Belgium. · WELBIO, 808 route de Lennik, 1070, Brussels, Belgium. · Pubmed 25884932
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
2014
  • BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25336696
  • 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory - J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Medical Oncology, Nepean Hospital, Penrith, NSW, Australia. · Breast International Group Executive Board. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium [2] Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium [3] Breast International Group Executive Board. · Pubmed 25225904
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. Electronic address: · Pubmed 25151406
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · OncoDNA, Gosselies, KU Leuven, Leuven. · Laboratory of Translational Genetics, KU Leuven, Leuven Vesalius Research Center, VIB, Leuven, Belgium. · Department of Biostatistic and Epidemiology, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Radiology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels. · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels · Pubmed 25185240
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2009
  • Medical Oncology Department, Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19228622
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
2015
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
  • Laboratory for the Structure and Function of Biological Membranes, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles (ULB), Bld du Triomphe 2, CP206/2, B1050 Brussels, Belgium. · Pubmed 24418921
2013
  • Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, 121 Boulevard de Waterloo, 1000 Brussels, Belgium. · Pubmed 23881035
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23778140
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
  • Laboratory for the Structure and Function of Biological Membranes, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles, Campus Plaine, Bld du Triomphe 2, CP206/2, B1050 Brussels, Belgium. · Pubmed 23689823
  • Laboratory for the Structure and Function of Biological Membranes, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles, Campus Plaine CP 206/2 Bâtiment BC, Blvd. du Triomphe, B-1050 Bruxelles, Belgium. · Pubmed 23662300
  • Breast Cancer Translational Research Laboratory, JC Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23638089
  • Breast Cancer Translation Research Laboratory J. C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23028037
2012
  • Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Pubmed 23014189
  • Breast Cancer Translational Research Laboratory J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 23012296
  • Breast Cancer Translational Research Unit, Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium. · Pubmed 22964299
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22454417
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 22652232
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22508827
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 22261811
2011
  • Laboratory of Cancer Epigenetics, Université Libre de Bruxelles, Faculty of Medicine, Brussels, Belgium. · Pubmed 22126295
  • Machine Learning Group, Computer Science Department, Université Libre de Bruxelles, Belgium. · Pubmed 22118187
  • Breast Cancer Translational Research Laboratory, Faculty of Medicine, Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles 1000, Belgium. · Pubmed 22043058
  • Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21910250
  • Translational Research Unit, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21738599
  • Breast Cancer Translational Research Laboratory JC Heuson, Université Libre de Bruxelles, Institut Jules Bordet, 125 Bld de Waterloo, 1000 Brussels, Belgium. · Pubmed 21422418
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Universite Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 20953831
2010
  • Jules Bordet Institute, Translational Research Unit, Universite Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 20943601
2009
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 19289395
Probable:    Institut Gustave Roussy      
2014
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.). · Pubmed 27557300
2015
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2014
  • Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
2013
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 23258741
Show More